PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis
- PMID: 22505939
- PMCID: PMC3299269
- DOI: 10.1155/2012/843085
PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis
Abstract
PI3K/AKT/PTEN pathway is important in the regulation of angiogenesis mediated by vascular endothelial growth factor in many tumors including leukemia. The signaling pathway is activated in leukemia patients as well as leukemia cell lines together with a decrease in the expression of PTEN gene. The mechanism by which the signaling pathway regulates angiogenesis remains to be further elucidated. However, it has become an attractive target for drug therapy against leukemia, because angiogenesis is a key process in malignant cell growth. In this paper, we will focus on the roles and mechanisms of PI3K/AKT/PTEN pathway in regulating angiogenesis.
Figures
References
-
- Piyaviriyakul S, Shimizu K, Asakawa T, Kan T, Siripong P, Oku N. Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs. Biological and Pharmaceutical Bulletin. 2011;34(3):396–400. - PubMed
-
- Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nature Protocols. 2010;5(4):628–635. - PubMed
-
- Zhang Y, Tang H, Cai J, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Letters. 2011;303(1):47–55. - PubMed
-
- Rouhi P, Lee SLC, Cao Z, Hedlund EM, Jensen LD, Cao Y. Pathological angiogenesis facilitates tumor cell dissemination and metastasis. Cell Cycle. 2010;9(5):913–917. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
